There are many drugs in the GLP-1 class, however, most are only available as injectable medications
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material
May 24, 2025: The MDL case count is now over 1,800 claims
The association between GLP-1RA use and a decreased risk of glaucoma, along with its potential implication for other neurodegenerative diseases, offers a promising avenue for targeted treatment as further research findings emerge
Louisianians may recognize the following brand names of GLP-1 weight loss drugs: Ozempic (semaglutide from Novo Nordisk) Rybelsus (semaglutide from Novo Nordisk) Wegovy (semaglutide from Novo Nordisk) Mounjaro (tirzepatide from Eli Lilly and Company) Zepbound (tirzepatide from Eli Lilly and Company) Saxenda (liraglutide from Novo Nordisk) Victoza (liraglutide from Novo Nordisk) Trulicity (dulaglutide from Eli Lilly and Company) Bursor & Fisher, P.A
Losing weight improves your insulin sensitivity, which, in turn, helps preserve muscle mass